Skip to main content

Advertisement

Log in

CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer

  • Chest Radiology
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

To develop a CT texture-based model able to predict epidermal growth factor receptor (EGFR)-mutated, anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinomas and distinguish them from wild-type tumors on pre-treatment CT scans.

Materials and methods

Texture analysis was performed using proprietary software TexRAD (TexRAD Ltd, Cambridge, UK) on pre-treatment contrast-enhanced CT scans of 84 patients with metastatic primary lung adenocarcinoma. Textural features were quantified using the filtration-histogram approach with different spatial scale filters on a single 5-mm-thick central slice considered representative of the whole tumor. In order to deal with class imbalance regarding mutational status percentages in our population, the dataset was optimized using the synthetic minority over-sampling technique (SMOTE) and correlations with textural features were investigated using a generalized boosted regression model (GBM) with a nested cross-validation approach (performance averaged over 1000 resampling episodes).

Results

ALK rearrangements, EGFR mutations and wild-type tumors were observed in 19, 28 and 37 patients, respectively, in the original dataset. The balanced dataset was composed of 171 observations. Among the 29 original texture variables, 17 were employed for model building. Skewness on unfiltered images and on fine texture was the most important features. EGFR-mutated tumors showed the highest skewness while ALK-rearranged tumors had the lowest values with wild-type tumors showing intermediate values. The average accuracy of the model calculated on the independent nested validation set was 81.76% (95% CI 81.45–82.06).

Conclusion

Texture analysis, in particular skewness values, could be promising for noninvasive characterization of lung adenocarcinoma with respect to EGFR and ALK mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

ALK:

Anaplastic lymphoma kinase

CT:

Computed tomography

CTTA:

CT texture analysis

EGFR:

Epidermal growth factor receptor

FBP:

Filtered back-projection

FFPE:

Formalin-fixed paraffin-embedded

FISH:

Fluorescence in situ hybridization

FOV:

Field of view

GBM:

Generalized boosted regression model

KV:

Kilovolt

MAS:

Milliampere per seconds

ML:

Milliliters

MRMR:

Minimum redundancy maximal relevancy filter

NSCLC:

Non-small cell lung cancer

S:

Seconds

SD:

Standard deviation

MOTE:

Synthetic minority oversampling technique

SSF:

Spatial scale filter

References

  1. Fitzmaurice C, Allen C et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3(524):548. https://doi.org/10.1001/jamaoncol.2016.5688

    Article  Google Scholar 

  2. Barlesi F, Mazieres J, Merlio J-P et al (2016) Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the french cooperative thoracic intergroup (IFCT). The Lancet 387:1415–1426. https://doi.org/10.1016/S0140-6736(16)00004-0

    Article  CAS  Google Scholar 

  3. Hanna N, Johnson D, Temin S et al (2017) Systemic therapy for stage IV non–small-cell lung cancer: American society of clinical oncology clinical practice guideline update. JCO 35:3484–3515. https://doi.org/10.1200/JCO.2017.74.6065

    Article  CAS  Google Scholar 

  4. Novello S, Barlesi F, Califano R et al (2016) Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v1–v27. https://doi.org/10.1093/annonc/mdw326

    Article  CAS  PubMed  Google Scholar 

  5. Rosell R, Carcereny E, Gervais R et al (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13:239–246. https://doi.org/10.1016/S1470-2045(11)70393-X

    Article  CAS  PubMed  Google Scholar 

  6. Kwak EL, Bang Y-J, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693–1703. https://doi.org/10.1056/NEJMoa1006448

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Choi YR, An JY, Kim MK et al (2013) The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool. Korean J Intern Med 28:660. https://doi.org/10.3904/kjim.2013.28.6.660

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lian W, Ouyang Y (2017) CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer. Oncology Letters 13:3415–3422. https://doi.org/10.3892/ol.2017.5921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. (2018) Clinical implications of transbronchial biopsy for surgically-resected non-small cell lung cancer. In Vivo https://doi.org/10.21873/invivo.11295

  10. Hofman P (2017) ALK status assessment with liquid biopsies of lung cancer patients. Cancers 9:106. https://doi.org/10.3390/cancers9080106

    Article  CAS  PubMed Central  Google Scholar 

  11. Lin C-C, Huang W-L, Wei F et al (2015) Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer. Expert Rev Mol Diagn 15:1427–1440. https://doi.org/10.1586/14737159.2015.1094379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Liu Y, Kim J, Balagurunathan Y et al (2016) Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clinical Lung Cancer 17:441-448.e6. https://doi.org/10.1016/j.cllc.2016.02.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Nair JKR, Saeed UA, McDougall CC et al (2020) Radiogenomic models using machine learning techniques to predict EGFR mutations in non-small cell lung cancer. Can Assoc Radiol J. https://doi.org/10.1177/0846537119899526

    Article  PubMed  Google Scholar 

  14. Mei D, Luo Y, Wang Y, Gong J (2018) CT texture analysis of lung adenocarcinoma: can radiomic features be surrogate biomarkers for EGFR mutation statuses. Cancer Imaging 18:52. https://doi.org/10.1186/s40644-018-0184-2

    Article  PubMed  PubMed Central  Google Scholar 

  15. Weiss GJ, Ganeshan B, Miles KA et al (2014) Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic. PLoS ONE 9:e100244. https://doi.org/10.1371/journal.pone.0100244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Digumarthy SR, Padole AM, Gullo RL et al (2019) Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status. Medicine 98 https://doi.org/10.1097/MD.0000000000013963

  17. Yoon HJ, Sohn I, Cho JH, et al (2015) Decoding Tumor Phenotypes for ALK ROS1 and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach, Medicine 94: 1753 https://doi.org/10.1097/MD.0000000000001753

  18. Martin V, Bernasconi B, Merlo E et al (2015) ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice. J Thorac Oncol 10:595–602. https://doi.org/10.1097/JTO.0000000000000444

    Article  CAS  PubMed  Google Scholar 

  19. Ravanelli M, Agazzi GM, Ganeshan B et al (2018) CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs). Eur J Radiol 109:130–135. https://doi.org/10.1016/j.ejrad.2018.10.016

    Article  PubMed  Google Scholar 

  20. Miles KA, Ganeshan B, Hayball MP (2013) CT texture analysis using the filtration-histogram method: what do the measurements mean? Cancer Imaging 13:400–406. https://doi.org/10.1102/1470-7330.2013.9045

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ng F, Kozarski R, Ganeshan B, Goh V (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82:342–348. https://doi.org/10.1016/j.ejrad.2012.10.023

    Article  PubMed  Google Scholar 

  22. Shafiq-ul-Hassan M, Zhang GG, Latifi K et al (2017) Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys 44:1050–1062. https://doi.org/10.1002/mp.12123

    Article  CAS  PubMed  Google Scholar 

  23. Blagus R, Lusa L (2013) SMOTE for high-dimensional class-imbalanced data. BMC Bioinformatics 14:106. https://doi.org/10.1186/1471-2105-14-106

    Article  PubMed  PubMed Central  Google Scholar 

  24. Peng H, Long F, Ding C (2005) Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 27:1226–1238. https://doi.org/10.1109/TPAMI.2005.159

    Article  PubMed  Google Scholar 

  25. R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria

    Google Scholar 

  26. Lin JJ, Riely GJ, Shaw AT (2017) Targeting ALK: precision medicine takes on drug resistance. Cancer Discov 7:137–155. https://doi.org/10.1158/2159-8290.CD-16-1123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Cai W, Lin D, Wu C et al (2015) Intratumoral heterogeneity of ALK-rearranged and ALK/EGFR coaltered lung adenocarcinoma. J Clin Oncol 33:3701–3709. https://doi.org/10.1200/JCO.2014.58.8293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zito Marino F, Marino FZ, Liguori G et al (2015) Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma. PLoS ONE 10:e0139264. https://doi.org/10.1371/journal.pone.0139264

    Article  CAS  PubMed  Google Scholar 

  29. Kobayashi Y, Mitsudomi T (2016) Not all epidermal growth factor receptor mutations in lung cancer are created equal: perspectives for individualized treatment strategy. Cancer Sci 107:1179–1186. https://doi.org/10.1111/cas.12996

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nagahashi M, Sato S, Yuza K et al (2018) Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma. J Surg Res 230:181–185. https://doi.org/10.1016/j.jss.2018.07.007

    Article  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlotta Pessina.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Consent to participate

Because of the retrospective nature of this study, the requirement for informed consent was waived by the local institutional review board of University of Brescia.

Ethical approval

Ethical approval was waived by the local institutional review board of University of Brescia (NP 4424) in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. The study was conducted in accordance with the ethical standards of the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 476 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agazzi, G.M., Ravanelli, M., Roca, E. et al. CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer. Radiol med 126, 786–794 (2021). https://doi.org/10.1007/s11547-020-01323-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-020-01323-7

Keywords

Navigation